{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-23-007120","form_type":"8-K","ticker":"BLGO","cik":"0000880242","company_name":"BIOLARGO, INC.","filed_at":"2023-03-20T23:59:59+00:00","discovered_at":"2026-05-14T18:03:48.365014+00:00","generated_at":"2026-06-17T23:22:38.602134+00:00","sec_items":["7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"BioLargo expects Q1 2023 revenue >4x YoY, seventh consecutive quarterly growth record","bullets":["Q1 2023 preliminary revenues expected to surpass Q4 2022 record; QoQ growth >50%.","Revenue driven by Pooph pet-odor product from Ikigai Marketing Works.","Company not yet profitable but net losses trending down as revenue increases.","2022 preliminary YoY revenue growth at least 125%; eighth consecutive annual growth.","Company expects to file 2022 annual report by end of March; earnings call April 3."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-23-007120","json":"https://secwatch.observer/filing/0001437749-23-007120.json","markdown":"https://secwatch.observer/filing/0001437749-23-007120.md","text":"https://secwatch.observer/filing/0001437749-23-007120.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/880242/000143774923007120/0001437749-23-007120-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/880242/000143774923007120/blgo20230317_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-17T23:22:38.602134+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}